BioCardia ($BCDA) Insider Trading & Smart Money Activity
BioCardia, Inc. ($BCDA) has 7 insider trades on file. In the last 12 months on the open market, 3 insiders bought ($109.42K) and no insider sold, net +$109.42K.
- Insider buyers (12 mo)
- 3
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- +$109.42K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
BCDA insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 5 · $106.39K | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 2 · $3.02K | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All BCDA insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Altman PeterPresident and CEO | Buy (Open-market buy) | 1K sh | $1.03K | +2.9% | — | |||||
| Insider | Altman PeterPresident and CEO | Buy (Open-market buy) | 1.90K sh | $2K | -3.8% | — | |||||
| Insider | Simon Stertzer | Buy (Open-market buy) | 39K sh | $39K | +24.0% | -9.0% | — | ||||
| Insider | Simon Stertzer | Buy (Open-market buy) | 70.20K sh | $64.58K | +24.7% | -6.2% | — | ||||
| Insider | Peter AltmanPresident and CEO | Buy (Open-market buy) | 800 sh | $768 | +12.4% | -7.2% | Read | ||||
| Insider | Peter AltmanPresident and CEO | Buy (Open-market buy) | 800 sh | $768 | +12.4% | -7.2% | Read | ||||
| Insider | Peter AltmanPresident and CEO | Buy (Open-market buy) | 1.50K sh | $1.27K | +11.6% | -12.6% | Read |
1W / 1M / 6M = how BCDA moved from the trade or filing date.
Insider trading in BCDA: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Altman Peter | President and CEO | 2 | +$3.02K | Sep 29, 2026 | |
| Simon Stertzer | 2 | +$103.58K | Jun 23, 2026 | ||
| Peter Altman | President and CEO | 3 | +$2.81K | Jun 18, 2026 |
Frequently asked questions
Are BCDA insiders buying or selling?
Over the last 12 months 3 insiders made 7 open-market purchases worth $109.42K and 0 insiders made 0 open-market sales worth $0, a net +$109.42K.
What is the latest insider trade in BCDA?
Altman Peter, President and CEO filed a buy (open-market buy) of 1K sh worth $1.03K on Sep 29, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.